Literature DB >> 23728802

Recent observations on site reactions in cattle to vaccination against contagious bovine pleuropneumonia (CBPP) using T1/44 vaccine in Zambia.

Geoffrey Munkombwe Muuka1, Webster Chikampa, Cornelius Mundia, Domenico Buonavoglia, Domenico Bounavoglia, Atilio Pini, Massimo Scacchia.   

Abstract

Contagious bovine pleuropneumonia (CBPP), a highly infectious and fatal disease of cattle present in many countries in sub-Saharan Africa, is usually controlled by mass vaccinations. However, vaccination against CBPP is known to cause site reactions in a percentage of cattle especially in primary vaccinations. In Zambia, a record of site reactions was kept for seven consecutive years from 2005 to 2011 to establish the level of the problem. In some areas, after 3 years of consecutive vaccination campaigns, immunization could not be implemented for a period of 2 years because of logistical difficulties or owner resistance. Whereas in the three preceding years when animals were vaccinated annually, site reactions were in the range of 6.2%; on resumption of vaccination in the herds that had not been immunized for 2 years, site reactions averaged 21.3%. This data shows that the T1/44 vaccine may cause severe local reactions in cattle if there is any break in annual vaccinations. It is therefore important for authorities to ensure that the cattle at risk of contracting CBPP are regularly vaccinated to avoid discouraging farmers from presenting their animals.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23728802     DOI: 10.1007/s11250-013-0429-9

Source DB:  PubMed          Journal:  Trop Anim Health Prod        ISSN: 0049-4747            Impact factor:   1.559


  8 in total

1.  Contagious bovine pleuropneumonia in Australia: some historic highlights from entry to eradication.

Authors:  L G Newton
Journal:  Aust Vet J       Date:  1992-12       Impact factor: 1.281

2.  Local reactions following C.B.P.P. vaccination in Zambia.

Authors:  S G Revell
Journal:  Trop Anim Health Prod       Date:  1973-11       Impact factor: 1.559

3.  Contagious bovine pleuropneumonia (lung sickness) in Africa.

Authors:  W Amanfu
Journal:  Onderstepoort J Vet Res       Date:  2009-03       Impact factor: 1.792

Review 4.  Challenges of controlling contagious bovine pleuropneumonia in sub-Saharan Africa: a Zambian perspective.

Authors:  Geoffrey Muuka; Nadi Songolo; Swithine Kabilika; Bernard M Hang'ombe; King S Nalubamba; John B Muma
Journal:  Trop Anim Health Prod       Date:  2012-07-29       Impact factor: 1.559

Review 5.  Contagious bovine pleuropneumonia. A review.

Authors:  E A ter Laak
Journal:  Vet Q       Date:  1992       Impact factor: 3.320

Review 6.  A brief history of vaccines and vaccination.

Authors:  M Lombard; P P Pastoret; A M Moulin
Journal:  Rev Sci Tech       Date:  2007-04       Impact factor: 1.181

7.  Plasma levels of TNF-α, IFN-γ, IL-4 and IL-10 during a course of experimental contagious bovine pleuropneumonia.

Authors:  Flavio Sacchini; Mirella Luciani; Romolo Salini; Massimo Scacchia; Attilio Pini; Rossella Lelli; Jan Naessens; Jane Poole; Joerg Jores
Journal:  BMC Vet Res       Date:  2012-04-25       Impact factor: 2.741

8.  To kill or not to kill: the eradication of contagious bovine pleuro-pneumonia in western Europe.

Authors:  John Fisher
Journal:  Med Hist       Date:  2003-07       Impact factor: 1.419

  8 in total
  2 in total

1.  Practices of traditional beef farmers in their production and marketing of cattle in Zambia.

Authors:  Chisoni Mumba; Barbara Häsler; John B Muma; Musso Munyeme; Doreen Chilolo Sitali; Eystein Skjerve; Karl M Rich
Journal:  Trop Anim Health Prod       Date:  2017-09-25       Impact factor: 1.559

2.  Development and Evaluation of a Combined Contagious Bovine Pleuropneumonia (CBPP) and Lumpy Skin Disease (LSD) Live Vaccine.

Authors:  Najete Safini; Soufiane Elmejdoub; Zahra Bamouh; Mohamed Jazouli; Jihane Hamdi; Zineb Boumart; Halima Rhazi; Khalid Omari Tadlaoui; Mehdi El Harrak
Journal:  Viruses       Date:  2022-02-11       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.